Tags » Gleevec

Orphan Drugs: The Power Of Multiple Indications

Orphan drug companies have used with tremendous success as part of their drug life cycle management, the strategy to extend the life of their product by devising a succession of multiple discrete indications for the orphan drug. 577 more words

Orphan Drug Development

Whoopsie!

Accidentally deleted my last post.  I’ll blame it on the “Gleevec Fog”.

To recap, my dosage of Gleevec was increased, then decreased due to unacceptable and overwhelming side effects.  80 more words

Chronic Myeloid Leukemia

IMATINIB

Imatinib

CAS No:-

IUPAC Name:- 4-[(4-Methyl-1-piperazinyl)methyl]-N-amino]phenyl]benzamide

M. P.:- 211-213 °C

MW: 493.604

4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{amino}phenyl)benzamide

-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{amino}phenyl)benzamide

N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-
yl)methyl)benzamide

Imatinib (INN), marketed by Novartis… 7,186 more words

Cancer

1st Month on Glivec

A week ago, dad went for an appointment with his oncologist. He had completed a month-course of Glivec. So far, he experienced swollen left foot which was sprained before. 1,126 more words

Dad's Health Journal

Another year. How time flies.

August 19, 2014 (Barely). It’s amazing how quickly time flies. It’s been an entire year since I posted last. Today marks my fourth anniversary of being diangosed with CML. 95 more words

Chris Berwick

14 Months and counting.

So far, so good.  I’ve thought a number of times about what to say at this point.  It’s all become pretty ordinary now.  Weight is stable, not losing, not gaining.   752 more words
GIST